Coherus BioSciences (CHRS) Appoints Georgia Erbez to its Board

On February 20, 2024, the Board of Directors (the “Board”) of Coherus BioSciences (NASDAQ: CHRS), increased the size of the Board from nine directors to ten directors and approved, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the appointment of Georgia Erbez to serve as a Class III director to fill the vacancy created by such increase. Ms. Erbez will hold this position until the Company’s 2026 annual meeting of stockholders or until her successor is duly elected and qualified, subject to her earlier death, resignation or removal. Ms. Erbez has also been appointed to serve on the audit committee of the Board.

You May Also Be Interested In

• ONE Nuclear Energy names CFO and nominates new board director
• Privia Health names Opella Ernest to its board of directors
• SolvChem secures expanded credit facility from Amegy Bank